abstract |
The present invention relates to inhibition of HIV integrase, as well as AIDS or ARC by administering a compound of formula I below, or a tautomer of the compound, or a pharmaceutically acceptable salt, solvate or prodrug thereof. Regarding treatment. [Chemical 1] (Wherein R 1 , R 2 and B 1 are as defined in the specification) |